Compare · ELV vs FTRE
ELV vs FTRE
Side-by-side comparison of Elevance Health Inc. (ELV) and Fortrea Holdings Inc. (FTRE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and FTRE operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $90.81B, about 57.9x FTRE ($1.57B).
- Over the past year, ELV is up 7.4% and FTRE is up 201.2% - FTRE leads by 193.8 points.
- FTRE has been more active in the news (6 items in the past 4 weeks vs 3 for ELV).
- FTRE has more recent analyst coverage (25 ratings vs 23 for ELV).
PerformanceELV+7.35%FTRE+201.18%
2025-06-09+0.00%2026-06-08
- Company
- Elevance Health Inc.
- Fortrea Holdings Inc.
- Price
- $418.31+0.63%
- $16.57+2.95%
- Market cap
- $90.81B
- $1.57B
- 1M return
- +12.19%
- +6.36%
- 1Y return
- +7.35%
- +201.18%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 3
- 6
- Recent ratings
- 23
- 25
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
- Elevance Health upgraded by Deutsche Bank with a new price target
- Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)
- Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)
- Director Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)
- Director Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)
- Director Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)
- Director Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)
- Director Dixon Robert L Jr was granted 563 shares, increasing direct ownership by 5% to 10,885 units (SEC Form 4)
Latest FTRE
- Chief Operating Officer Morais Mark A. converted options into 11,006 shares and sold $75,374 worth of shares (4,866 units at $15.49), increasing direct ownership by 9% to 76,039 units (SEC Form 4) (tax withholding)
- Chief Financial Officer Mcconnell Jill G. converted options into 11,006 shares and sold $75,374 worth of shares (4,866 units at $15.49), increasing direct ownership by 8% to 78,416 units (SEC Form 4) (withholding obligation)
- Fortrea to Attend Jefferies Global Healthcare Conference
- Chief Accounting Officer Parks Robert sold $26,880 worth of shares (2,000 units at $13.44), decreasing direct ownership by 9% to 20,389 units (SEC Form 4)
- Director Neupert Peter M converted options into 148,536 shares, increasing direct ownership by 151% to 246,668 units (SEC Form 4)
- SEC Form 144 filed by Fortrea Holdings Inc.
- SEC Form 10-Q filed by Fortrea Holdings Inc.
- Fortrea Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Fortrea Reports First Quarter 2026 Results
- SEC Form DEFA14A filed by Fortrea Holdings Inc.